Equity Analysis

Quarterly Results

    Sunrest Lifescience Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    91669
    INE0PLZ01012
    33.0471663
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    SUNREST
    99.25
    22.57
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0.53
    10
    0
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2023Jun 2023Mar 2023
Gross Sales6.845.646.84
Other Operating Income0.000.000.00
Other Income 0.000.000.03
Total Income6.845.646.87
Total Expenditure 6.194.637.16
PBIDT0.651.00-0.28
Interest 0.010.010.04
PBDT0.651.00-0.32
Depreciation0.020.020.03
Tax-0.610.22-0.02
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.010.00-0.02
Reported Profit After Tax1.230.75-0.32
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item1.230.75-0.32
EPS (Unit Curr.)4.122.500.00
EPS (Adj) (Unit Curr.)4.122.500.00
Calculated EPS (Unit Curr.)4.122.50-1.07
Calculated EPS (Adj) (Unit Curr.)4.122.50-1.07
Calculated EPS (Ann.) (Unit Curr.)16.4610.01-4.27
Calculated EPS (Adj) (Ann.) (Unit Curr.)16.4610.01-4.27
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity3.003.003.00
Reserve & Surplus0.000.870.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)9.5017.73-4.09
PBDTM(%)9.5017.73-4.68
PATM(%)17.9813.30-4.68
Dividend Per Share(Rs)0.000.000.00
Diluted EPS0.002.500.00